Dermatologic Surgery, an esteemed journal published by Lippincott Williams & Wilkins, serves as a vital resource in the field of dermatology, surgery, and medicine. With an impressive impact factor reflecting its significant contribution to the scientific community, this journal ranks in the top quartiles (Q2 in Dermatology and Medicine, Q1 in Surgery) and offers insights that are crucial for both clinical practice and academic research. Spanning a history from 1995 to 2024, it encompasses a wealth of knowledge on therapeutic advancements, surgical techniques, and innovative procedures pertinent to dermatologic surgery. Although it does not currently offer open access, the journal is highly respected among professionals and researchers, making it a key reference point for those engaged in cutting-edge dermatological care and research. Located in the heart of Philadelphia, Dermatologic Surgery is dedicated to enhancing the understanding and application of surgical dermatology through a rigorous peer-review process and a commitment to disseminating high-quality research.

Annals of Dermatology is a prestigious academic journal published by the Korean Dermatological Association, focusing on the latest research and advancements in the field of dermatology. With a commitment to advancing knowledge in skin health and disease, this journal serves as a vital resource for researchers, clinicians, and students working in dermatology and related disciplines. Since its inception in 1989, it has evolved to consolidate its position in the academic community, boasting a Q2 ranking in the 2023 Dermatology category and a Scopus rank of #87 out of 142, placing it in the 39th percentile. Although it operates under a subscription model, the journal's impact factor reflects its significance in advancing dermatological research, attracting innovative studies and reviews that shape clinical practice. With a publication history extending from 1989 to 1996 and then from 2008 to the present, Annals of Dermatology continues to be an essential publication for those devoted to improving skin health.

Actas Dermo-Sifiliograficas, published by Elsevier España, stands as a pivotal resource in the realms of dermatology, histology, and pathology and forensic medicine. With its ISSN of 0001-7310 and E-ISSN 1578-2190, this esteemed journal has transitioned to an Open Access model since 2020, facilitating broader dissemination of impactful research. Operating from its Madrid headquarters, it has been a vital platform for scholarly exchange since its inception in 1945, continuing through its converged years until 2024. The journal holds a Q3 ranking in dermatology, histology, and pathology and forensic medicine as of 2023, reflecting its relevance in the academic community where it ranks 79th in dermatology and 126th in pathology among its peers. With a commitment to advancing knowledge and practice in its fields, Actas Dermo-Sifiliograficas serves as an essential repository for researchers, professionals, and students seeking to engage with the latest findings and innovative perspectives in skin and disease research.

The American Journal of Clinical Dermatology, published by Adis International Ltd, is a leading peer-reviewed journal dedicated to advancing the field of dermatology. With a notable impact factor and a prestigious Q1 rank in both Dermatology and Miscellaneous Medicine categories, this journal stands out as a valuable resource for researchers and clinicians alike, offering cutting-edge insights into clinical practice and innovative treatment strategies. Its comprehensive scope encompasses a broad range of topics within dermatology, addressing both common and rare conditions, with a focus on emerging therapies and technologies. As it converges its publication years from 2000 to 2024, the journal remains an essential platform for disseminating high-quality research to professionals striving to improve patient care and outcomes. With the ISSN 1175-0561 and E-ISSN 1179-1888, the American Journal of Clinical Dermatology facilitates greater accessibility to pivotal findings within the field, making it an indispensable resource for anyone involved in dermatological research and practice.

Dermatology Research and Practice is a premier open access journal published by HINDAWI LTD, dedicated to advancing the field of dermatology since its establishment in 2009. With a respectable impact factor and a ranking of #42 out of 142 in the Scopus Medicine - Dermatology category, the journal stands in the 70th percentile, reflecting its influence and relevance in contemporary dermatological research. Based in Egypt, it provides a platform for groundbreaking studies that shape clinical practice and policy worldwide. The journal covers a wide range of topics within dermatology, including but not limited to clinical research, epidemiology, and patient care, making it an essential resource for researchers, healthcare professionals, and students seeking to enhance their understanding and contribute to the field. Emphasizing open access, Dermatology Research and Practice ensures that vital research findings are readily available to the global community, fostering collaboration and innovation in dermatology.

CLINICAL AND EXPERIMENTAL DERMATOLOGY is a prominent journal in the field of dermatology, published by Oxford University Press. With an ISSN of 0307-6938 and an E-ISSN of 1365-2230, this journal has been a vital resource for researchers and practitioners since its inception in 1976. Recognized as a Q2 journal within the category of dermatology for 2023, it holds a respectable position, ranking #54 among 142 journals in this discipline, placing it in the 62nd percentile on Scopus. The journal is dedicated to publishing high-quality research that spans clinical and experimental aspects of dermatological science, making it an essential source of knowledge for advancing understanding and treatment of skin disorders. Although it operates on a traditional subscription model without open access options, its contributions to the field are significant, influencing both clinical practices and academic research. Researchers, clinicians, and students alike will find vital insights and contemporary themes presented in its pages, supporting ongoing education and innovation in dermatology.

JAMA Dermatology, an esteemed publication by the American Medical Association, is positioned at the forefront of dermatological research and clinical practice. With an ISSN of 2168-6068 and an E-ISSN of 2168-6084, this journal underscores a commitment to disseminating high-quality and impactful research within the field. Notably ranked Q1 in both Dermatology and Miscellaneous Medicine for 2023, JAMA Dermatology ranks among the top journals in its category, holding the impressive 3rd position out of 142 in Scopus's dermatology rankings, placing it in the 98th percentile. With converged years extending from 2013 to 2024, the journal emphasizes timely and critical advancements in dermatological science. Furthermore, as a champion of open access, it encourages a broad dissemination of knowledge, making essential research accessible to a wider audience. Researchers, professionals, and students alike will find JAMA Dermatology to be an invaluable resource for the latest findings, innovative therapies, and in-depth reviews that shape the future of dermatological health.

The Indian Journal of Dermatology Venereology & Leprology (IJDL) is a premier open-access journal dedicated to the fields of dermatology, venereology, and leprology, published by SCIENTIFIC SCHOLAR LLC since 2004. With a rich historical background dating back to 1976, the journal has established itself as a reputable source for high-quality research and clinical advancements in these disciplines. The IJDL is recognized for its academic rigor, boasting a 2023 category quartile ranking of Q2 in Dermatology and Q3 in Infectious Diseases, indicating its significant contribution to these fields. With an accessible online platform, researchers, practitioners, and students alike can readily explore the latest studies, case reports, and reviews that address key issues affecting public health, particularly in India and beyond. The journal serves not only as a repository of valuable knowledge but also as a vital forum for the exchange of ideas, fostering collaboration and innovation among professionals dedicated to enhancing skin health and combating infectious diseases.

Journal of Drugs in Dermatology, an esteemed publication in the field of dermatology, serves as a vital resource for researchers, clinicians, and healthcare professionals dedicated to advancing knowledge and practices in skin-related therapies and treatments. Established in 2002 and published in the United States, this journal focuses on a wide range of topics pertinent to dermatological pharmacology and therapeutics, reflecting contemporary scientific advancements and innovative approaches to patient care. With a strong presence in Scopus rankings, situating it at rank #73 within the dermatology category, and achieving a commendable Q2 quartile classification in both dermatology and general medicine categories, the journal is committed to enhancing understanding of drug efficacy and safety in dermatological conditions. While the journal maintains a traditional access model, its impact factor underscores its significance in the research community, supporting the ongoing dialogue between academia and clinical practice. We invite professionals and students alike to explore the latest findings and contribute to the progressive discourse on dermatological treatments through this important publication.

ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE is a distinguished journal that serves as a vital platform for disseminating innovative research and insightful reviews in the field of dermatology and venereology. Published by MASSON EDITEUR, this journal has been a cornerstone for professionals and researchers since its inception in 1977, offering a wealth of knowledge that spans decades. With its ISSN 0151-9638 and E-ISSN 2214-5451, it is indexed within leading databases, ensuring that the published work reaches a broad audience. The journal currently holds a Q3 ranking in the dermatology category, reflecting its commitment to quality and rigorous peer-review processes. While the journal is not open access, it provides an extensive archive of valuable studies that contribute to advancements in skin health and treatment methodologies. Located in Issy-les-Moulineaux, France, ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE continues to attract submissions from esteemed professionals, enhancing its reputation as a crucial resource for those dedicated to the ongoing development of dermatological sciences.